Crossref journal-article
Elsevier BV
Neurobiology of Aging (78)
Bibliography

Jack, C. R., Petersen, R. C., Grundman, M., Jin, S., Gamst, A., Ward, C. P., Sencakova, D., Doody, R. S., & Thal, L. J. (2008). Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. Neurobiology of Aging, 29(9), 1285–1295.

Authors 9
  1. Clifford R. Jack (first)
  2. Ronald C. Petersen (additional)
  3. Michael Grundman (additional)
  4. Shelia Jin (additional)
  5. Anthony Gamst (additional)
  6. Chadwick P. Ward (additional)
  7. Drahomira Sencakova (additional)
  8. Rachelle S. Doody (additional)
  9. Leon J. Thal (additional)
References 44 Referenced 113
  1. 10.1212/01.WNL.0000132520.69612.AB / Neurology / Predicting the rate of cognitive decline in aging and early Alzheimer disease by Adak (2004)
  2. {'key': '10.1016/j.neurobiolaging.2007.03.004_bib2', 'first-page': '637', 'article-title': 'Clinical Dementia Rating (CDR)', 'volume': '24', 'author': 'Berg', 'year': '1988', 'journal-title': 'Psychopharmacol. Bull.'} / Psychopharmacol. Bull. / Clinical Dementia Rating (CDR) by Berg (1988)
  3. 10.1126/science.8346443 / Science / Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families by Corder (1993)
  4. 10.1212/01.WNL.0000130531.90205.EF / Neurology / Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia by DeCarli (2004)
  5. 10.1212/WNL.59.5.746 / Neurology / Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes by den Heijer (2002)
  6. 10.1016/S0197-4580(01)00271-8 / Neurobiol. Aging / MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease by Dickerson (2001)
  7. 10.1212/01.WNL.0000044400.11317.EC / Neurology / Atrophy rates of entorhinal cortex in AD and normal aging by Du (2003)
  8. 10.1212/01.WNL.0000144279.21502.B7 / Neurology / Impact of APOE in mild cognitive impairment by Farlow (2004)
  9. 10.1001/archneur.62.6.953 / Arch. Neurol. / Sex, apolipoprotein E e4 status, and hippocampal volume in mild cognitive impairment by Fleisher (2005)
  10. 10.1016/0022-3956(75)90026-6 / J. Psychiatr. Res. / “Mini Mental State”: A practical method for grading the cognitive state of patients for the clinician by Folstein (1975)
  11. 10.1212/01.WNL.0000159743.08996.99 / Neurology / Effects of AB immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease by Fox (2005)
  12. 10.1002/jmri.1880070620 / J. Magn. Reson. Imag. / Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease by Fox (1997)
  13. 10.1016/S0140-6736(96)05228-2 / Lancet / Visualization and quantification of rates of atrophy in Alzheimer's disease by Fox (1996)
  14. 10.1212/WNL.52.8.1687 / Neurology / Correlation between rates of brain atrophy and cognitive decline in AD by Fox (1999)
  15. 10.1109/42.640753 / IEEE Trans. Med. Imag. / The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI by Freeborough (1997)
  16. 10.1002/ana.410370509 / Ann. Neurol. / Gene dose of the E4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease by Frisoni (1995)
  17. 10.1001/archneur.61.1.59 / Arch. Neurol. / Mild cognitive impairment can be distinguished from Alzheimer's disease and normal aging for clinical trials by Grundman (2004)
  18. 10.1002/jmri.10325 / JMRI / Methodological considerations for measuring rates of brain atrophy by Gunter (2003)
  19. 10.1176/appi.ajp.162.4.676 / Am. J. Psychiatry / Does Donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease? by Hashimoto (2005)
  20. 10.1212/WNL.42.1.183 / Neurology / MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease by Jack (1992)
  21. 10.1212/WNL.55.4.484 / Neurology / Rates of hippocampal atrophy in normal aging, mild cognitive impairment, and Alzheimer's disease by Jack (2000)
  22. 10.1212/WNL.52.7.1397 / Neurology / Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment by Jack (1999)
  23. 10.1212/WNL.51.4.993 / Neurology / The rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease by Jack (1998)
  24. 10.1002/ana.410430307 / Ann. Neurol. / Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease by Jack (1998)
  25. 10.1212/WNL.49.3.786 / Neurology / Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease by Jack (1997)
  26. 10.1212/01.WNL.0000110315.26026.EF / Neurology / Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD by Jack (2004)
  27. 10.1212/01.wnl.0000180958.22678.91 / Neurology / Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI by Jack (2005)
  28. 10.1212/01.WNL.0000042480.86872.03 / Neurology / MRI as a biomarker of disease progression in a therapeutic trial of Milameline for Alzheimer's by Jack (2003)
  29. 10.1148/radiology.172.2.2748838 / Radiology / Anterior temporal lobes and hippocampal formations: normative volumetric measurements for MR images in young adults by Jack (1989)
  30. 10.1212/WNL.48.5.1297 / Neurology / Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia by Kaye (1997)
  31. 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I / Ann. Neurol. / Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease by Killiany (2000)
  32. 10.1212/WNL.58.8.1188 / Neurology / MRI measures of entorhinal cortex vs hippocampus in preclinical AD by Killiany (2002)
  33. 10.1176/appi.ajp.160.11.2003 / Am. J. Psychiatry / Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease by Krishnan (2003)
  34. 10.1212/WNL.34.7.939 / Neurology / Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease by McKhann (1984)
  35. 10.1212/01.wnl.0000172913.88973.0d / Neurology / Longitudinal volumetric MRI change and rate of cognitive decline by Mungas (2005)
  36. {'key': '10.1016/j.neurobiolaging.2007.03.004_bib36', 'first-page': '326', 'article-title': "Normal aging, mild cognitive impairment, and early Alzheimer's disease", 'volume': '1', 'author': 'Petersen', 'year': '1995', 'journal-title': 'Neurologist'} / Neurologist / Normal aging, mild cognitive impairment, and early Alzheimer's disease by Petersen (1995)
  37. {'key': '10.1016/j.neurobiolaging.2007.03.004_bib37', 'first-page': '408', 'article-title': "Mayo Clinic Alzheimer's Disease patient registry", 'volume': '2', 'author': 'Petersen', 'year': '1990', 'journal-title': 'Aging'} / Aging / Mayo Clinic Alzheimer's Disease patient registry by Petersen (1990)
  38. 10.1001/jama.1995.03520400044042 / JAMA / Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory impaired individuals by Petersen (1995)
  39. 10.1001/archneur.56.3.303 / Arch. Neurol. / Mild cognitive impairment clinical characterization and outcome by Petersen (1999)
  40. 10.1056/NEJMoa050151 / N. Engl. J. Med. / Vitamin E and donepezil for the treatment of mild cognitive impairment by Petersen (2005)
  41. 10.1212/WNL.48.4.985 / Neurology / Apolipoprotein E4 allele and hippocampal volume in twins with normal cognition by Plassman (1997)
  42. 10.1073/pnas.90.5.1977 / Proc. Natl. Acad. Sci. / Apolipoprotein E: high acidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease by Strittmatter (1993)
  43. {'key': '10.1016/j.neurobiolaging.2007.03.004_bib43', 'first-page': '132', 'article-title': 'A normalized entropy measure for multimodality image alignment', 'volume': '3338', 'author': 'Studholme', 'year': '1998', 'journal-title': 'Proc. SPIE Int. Soc. Opt. Eng.'} / Proc. SPIE Int. Soc. Opt. Eng. / A normalized entropy measure for multimodality image alignment by Studholme (1998)
  44. 10.1007/s004150050387 / J. Neurol. / Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment by Visser (1999)
Dates
Type When
Created 18 years, 4 months ago (April 24, 2007, 12:26 p.m.)
Deposited 6 years, 7 months ago (Jan. 7, 2019, 8:26 p.m.)
Indexed 1 day, 17 hours ago (Sept. 4, 2025, 9:40 a.m.)
Issued 17 years ago (Sept. 1, 2008)
Published 17 years ago (Sept. 1, 2008)
Published Print 17 years ago (Sept. 1, 2008)
Funders 0

None

@article{Jack_2008, title={Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI}, volume={29}, ISSN={0197-4580}, url={http://dx.doi.org/10.1016/j.neurobiolaging.2007.03.004}, DOI={10.1016/j.neurobiolaging.2007.03.004}, number={9}, journal={Neurobiology of Aging}, publisher={Elsevier BV}, author={Jack, Clifford R. and Petersen, Ronald C. and Grundman, Michael and Jin, Shelia and Gamst, Anthony and Ward, Chadwick P. and Sencakova, Drahomira and Doody, Rachelle S. and Thal, Leon J.}, year={2008}, month=sep, pages={1285–1295} }